ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433,791 | +62.2% | 33,013 | +55.5% | 0.00% | – |
| Q2 2023 | $267,473 | -7.9% | 21,228 | -4.6% | 0.00% | – |
| Q1 2023 | $290,480 | -72.9% | 22,259 | -63.4% | 0.00% | – |
| Q4 2022 | $1,072,071 | -21.5% | 60,775 | -32.2% | 0.00% | -100.0% |
| Q3 2022 | $1,366,000 | -38.2% | 89,695 | -39.8% | 0.00% | 0.0% |
| Q2 2022 | $2,211,000 | +415.4% | 149,112 | +682.6% | 0.00% | – |
| Q1 2022 | $429,000 | -18.4% | 19,053 | -33.2% | 0.00% | – |
| Q4 2021 | $526,000 | -36.6% | 28,531 | -54.0% | 0.00% | – |
| Q3 2021 | $829,000 | -75.8% | 61,967 | -66.6% | 0.00% | -100.0% |
| Q2 2021 | $3,432,000 | +230.3% | 185,411 | +167.9% | 0.00% | – |
| Q1 2021 | $1,039,000 | -24.3% | 69,203 | -27.2% | 0.00% | -100.0% |
| Q4 2020 | $1,372,000 | +182.3% | 95,003 | +59.1% | 0.00% | – |
| Q3 2020 | $486,000 | +7.0% | 59,694 | -11.0% | 0.00% | – |
| Q2 2020 | $454,000 | +291.4% | 67,078 | +306.7% | 0.00% | – |
| Q1 2020 | $116,000 | -74.2% | 16,493 | -63.9% | 0.00% | -100.0% |
| Q4 2019 | $449,000 | +283.8% | 45,693 | +355.4% | 0.00% | – |
| Q2 2019 | $117,000 | -14.0% | 10,034 | -29.8% | 0.00% | – |
| Q1 2019 | $136,000 | -91.8% | 14,303 | -87.5% | 0.00% | -100.0% |
| Q4 2017 | $1,660,000 | +93.5% | 114,068 | +89.3% | 0.01% | +66.7% |
| Q3 2017 | $858,000 | +241.8% | 60,267 | +204.7% | 0.00% | +200.0% |
| Q1 2017 | $251,000 | -69.4% | 19,782 | -75.3% | 0.00% | -75.0% |
| Q4 2016 | $819,000 | +506.7% | 80,201 | +685.2% | 0.00% | +300.0% |
| Q3 2016 | $135,000 | -83.4% | 10,214 | -84.0% | 0.00% | -75.0% |
| Q2 2016 | $813,000 | +405.0% | 64,000 | +425.2% | 0.00% | +300.0% |
| Q1 2016 | $161,000 | -90.4% | 12,185 | -88.9% | 0.00% | -90.0% |
| Q4 2015 | $1,684,000 | +152.5% | 109,463 | +103.4% | 0.01% | +150.0% |
| Q3 2015 | $667,000 | +353.7% | 53,810 | +401.4% | 0.00% | +300.0% |
| Q2 2015 | $147,000 | -55.0% | 10,732 | -40.9% | 0.00% | -75.0% |
| Q1 2014 | $327,000 | – | 18,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |